The soft-tissue evidence for both compounds is overwhelmingly rodent and cell-culture
Specifically, the FDA warns that compounded drugs containing Selank pose a risk for immunogenicity, a state in which the body perceives a substance as a threat and mounts a potentially life-threatening immune response against it.21 22 The FDA qualifies the risk to certain routes of administration but doesnt specify which routes, and also notes a lack of safety information concerning Selank administered to humans.21 Our relationships with peptide providers have given us additional insights into this topic, but the side effects theyve shared with us are no different from those of most therapeutic peptides weve covered ( injection site reactions , stomach discomfort , nausea , headaches , and dizziness )
ranges vary widely between sources, which is itself a reflection of the absent human dosing data
Breaking any of them compromises the peptide, reduces potency, and can introduce safety concerns
Because all three peptides share one vial, you cannot draw a single component separately
It is a medical assessment
